跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BONJESTA 20 MG/20 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BONJESTA 20 MG/20 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA
Approved
STANDARD
BONJESTA 20 MG/20 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA
Exeltis Healthcare S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 4, 2023
Approval ID
25ad6c88fd76c8ff
Company
Exeltis Healthcare S.L.
Type
Standard
Approval Details
Approval Id
25ad6c88fd76c8ff
Drug Cima Aemps Name
BONJESTA 20 MG/20 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA
Register Number
88756
Holder Company Name
Exeltis Healthcare S.L.
Marketing Company Name
Exeltis Healthcare S.L.
Authorization Date
2023-04-04
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
20 mg /20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Exeltis Healthcare S.L.
Active Ingredients
DOXILAMINA, HIDROGENOSUCCINATO DE
20 mg
PIRIDOXINA HIDROCLORURO
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 4, 2023
Approval ID
25ad6c88fd76c8ff
Type
Standard
Back to CIMA-AEMPS Approvals